How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.

Sieuwerts, Anieta M

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Oct 2005 - 7311-21 p. digital

Publication Type: Journal Article

1078-0432

10.1158/1078-0432.CCR-05-0560 doi


ADAM Proteins--genetics
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal--therapeutic use
Breast Neoplasms--drug therapy
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Matrix Metalloproteinase 2--genetics
Matrix Metalloproteinase 9--genetics
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Predictive Value of Tests
Prognosis
RNA, Messenger--genetics
Receptors, Estrogen--genetics
Receptors, Progesterone--genetics
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction
Survival Analysis
Tamoxifen--therapeutic use